The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: Protective effect of caffeic acid phenethyl ester

Toxicology and Industrial Health

Volumn 21, Issue 2, 2005, Pages 67-73

  Yilmaz, H Ramazan ^a   Sogut, Sadik ^b   Ozyurt, Birsen ^c   Ozugurlu, Fikret ^c   Sahin, Semsettin ^c   Isik, Bunyamin ^d   Uz, Ebru ^d   Ozyurt, Huseyin ^c  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c GAZIOSMANPASA UNIVERSITY   (Turkey)

^d FATIH UNIVERSITY   (Turkey)

Author keywords

antioxidant enzymes; CAPE; cisplatin; liver; nitric oxide

Indexed keywords

ADENOSINE DEAMINASE; ANTIOXIDANT; CAFFEIC ACID PHENETHYL ESTER; CATALASE; CISPLATIN; MALONALDEHYDE; NITRIC OXIDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME ASSAY; LIVER PROTECTION; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PROTEIN DETERMINATION; RAT; SPECTROPHOTOMETRY;

ADENOSINE DEAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS; CAFFEIC ACIDS; CATALASE; CISPLATIN; LIVER; MALONDIALDEHYDE; NITRIC OXIDE; PHENYLETHYL ALCOHOL; PROTECTIVE AGENTS; RATS; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMALIA;

EID: 20544463473     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1191/0748233705th216oa     Document Type: Article

References (43)

1. Aebi, H. 1974: Catalase. In Bergmeyer, H. U., editor, Methods of enzymatic analysis. New York and London: Academic Press, 673-677.
2. Baliga, R., Zhang, Z., Baliga, M. et al. 1998: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney International 53, 394-401.
3. Cavalli, F., Tschopp, L., Sonntag, R. W. and Zimmermann, A. 1978: A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment. Cancer Treatment Reports 62, 2125-2126.
4. Cersosimo, R. J. 1993: Hepatotoxicity associated with cisplatin chemotherapy. Annals of Pharmacotherapy 27, 438-441.
5. Cortas, N. K. and Wakid, N. W. 1990: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clinical Chemistry 36, 1440-1443.
6. Draper, H. H. and Hadley, M. 1990: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymology 186, 421-431.
7. Durak, I., Yurtarslani, Z., Canbolat, O. and Akyol, O. 1993: A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clinica Chimica Acta 214, 103-104.
8. Fadillioglu, E., Oztas, E., Erdogan, H. et al. 2004: Protective effects of caffeic acid Phenethyl ester on doxorubicin-induced cardiotoxicity in rats. Journal of Applied Toxicology 24, 47-52.
9. Frenkel, K., Wei, H., Bhimani, R. et al. 1993: Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Research 53, 1255-1261.
10. Giusti, G. 1974: Adenosine deaminase. In Bergmeyer, M. V., editor, Methods of enzymatic analysis, second edition. New York: Academic Press, 1092-1098.
11. Grunberger, D., Banerjee, R., Eisinger, K. et al. 1988: Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 44, 230-232.
12. Hepsen, I. F., Er, H. and Cekic, O. 1999: Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. Ophthalmic Research 31, 426-431.
13. Hesketh, M. A., Twaddell, T. and Finn, A. 1990: A possible role for cisplatin (DDP) in the transient hepatic enzyme elevations noted after ondansetron administration. Proceedings of the American Association for Clinical Oncology 9, 323-323.
14. Ilhan, A., Koltuksu, U., Ozen, S. et al. 1999: The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. European Journal of Cardio-thoracic Surgery 16, 458-463.
15. Irmak, M. K., Fadillioglu, E., Gulec, M. et al. 2002: Effects of electromagnetic radiation from a cellular telephone on the oxidant and antioxidant levels in rabbits. Cell Biochemistry and Function 20, 279-283.
16. Khayyal, M. T., el-Ghazaly, M. A. and el-Khatib, A. S. 1993: Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Under Experimental and Clinical Research 19, 197-203.
17. Kim, S. H., Hong, K. O., Chung, W. Y. et al. 2004: Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicology and Applied Pharmacology 196, 346-355.
18. Koltuksuz, U., Ozen, S., Uz, E. et al. 1999: Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. Journal Pediatric Surgery 34, 1458-1462.
19. Liu, J., Liu, Y., Habeebu, S. S. M. and Klassen, C. D. 1998: Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicology and Applied Pharmacology 149, 24-31.
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. 1951: Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 193, 265-275.
21. Madias, N. E. and Harrington, J. T. 1978: Platinum nephrotoxi-city. The American Journal of Medicine 65, 307-314.
22. Mansour, M. A., Mostafa, A. M., Nagi, M. N. et al. 2002: Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 132, 123-128.
23. Masuda, H., Tanaka, T. and Takahama, U. 1994: Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochemical and Biophysical Research Communications 203, 1175-1180.
24. Matsushima, H., Yonemura, K., Ohishi, K. and Hishida, A. 1998: The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. The Journal of Laboratory and Clinical Medicine 131, 518-526.
25. Mollman, J. E., Glover, D. J., Hogan, W. M. and Furman, R. E. 1988: Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721. Cancer 61, 2192-2195.
26. Naziroglu, M., Karaoglu, A. and Aksoy, A. O. 2004: Selenium and high dose vitamine E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 195, 221-230.
27. Ozen, S., Akyol, O., Iraz, M. et al. 2004: Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. Journal of Applied Toxicology 24, 27-35.
28. Ozyurt, H., Sogut, S., Yildirim, Z. et al. 2004: Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clinica Chimica Acta 339, 65-75.
29. Peresleni, T., Noiri, E., Bahou, W. F. and Goligorsky, M. S. 1996: Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. The American Journal of Physiology 270, F971-F977.
30. Prajda, N. and Weber, G. 1975: Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Letters 59, 245-249.
31. Rosenberg, B. 1977: Noble metal complexes in cancer chemotherapy. Advances in Experimental Medicine and Biology 91, 129-150.
32. Scapagnini, G., Foresti, R., Calabrese, V. et al. 2002: Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1inducers. MolecularPharmacology 61, 554-561.
33. Sogut, S., Zoroglu, S. S., Ozyurt, H. et al. 2003: Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clinica Chimica Acta 331, 111-117.
34. Sogut, S., Kotuk, M., Yilmaz, H. R. et al. 2004: In vivo evidence suggestion a role for purine catabolizing enzymes in pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity. Cell Biochemistry and Function 22, 157-162.
35. Song, Y. S., Park, E. H., Hur, G. M. et al. 2002: Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Letters 175, 53-61.
36. Sud'ina, G. F., Mirzoeva, O. K., Pushkareva, M. A. et al. 1993: Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Letters 329, 21-24.
37. Sun, Y., Oberley, L. W. and Li, Y. 1988: A simple method for clinical assay of superoxide dismutase. Clinical Chemistry 34, 497-500.
38. Uz, E., Sogut, S., Sahin, S. et al. 2002: The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion. World Journal of Urology 20, 264-270.
39. Van Basten, J. P., Schafford-Koops, H., Sleijfer, D. T. et al. 1997: Current concept about testicular cancer. The European Journal of Surgery 23, 354-360.
40. Vermorken, J. B. and Pinedo, H. M. 1982: Gastrointestinal toxicity of cis -diammine-dichloroplatinum(II). The Netherlands Journal of Medicine 25, 270-274.
41. Von Hoff, D. D., Schilsky, R., Reichert, C. M. et al. 1979: Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treatment Reports 63, 1527-1531.
42. Yildirim, Z., Sogut, S., Odaci, E. et al. 2003: Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacological Research 47, 149-156.
43. Zicca, A., Cafaggi, S., Mariggio, M. A. et al. 2002: Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. European Journal of Pharmacology 442, 265-272.